HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of International Heart Congress

June 05-07,2025 | Hybrid Event

June 05 -07, 2025 | Rome, Italy
Heart Congress 2025

Iron deficiency in chronic heart failure patients at the University Teaching Hospital in Lusaka, Zambia

Sandra Lungu, Speaker at Cardiovascular Conference
Lusaka Apex Medical University, Zambia
Title : Iron deficiency in chronic heart failure patients at the University Teaching Hospital in Lusaka, Zambia

Abstract:

Iron plays a key role in oxygen uptake, transport, storage, and oxidative metabolism in the muscle including myocardium. Iron deficiency (ID) in chronic heart failure (CHF) patients has a mortality of 35% is reported at the university teaching hospital (UTH). Information on ID in CHF patients at UTH is scarce and conflicting. The purpose of this study was to determine the iron status in CHF patients at UTH in Lusaka.

Methodology: CHF patients of New York Heart Association (NYHA) functional class II to IV participated in this cross sectional study. Interviews and file reviews were used to collect demographic data. ID was defined as transferrin saturation of less than 20% and ferritin concentration of less than 100μg/L. A statistical significance of P < 0.05 was used at 95% confidence interval. The data obtained were analyzed using STATA version thirteen and the chi-square test/fisher’s exact test and multivariate binary logistic regression were used to analyze the results.

Findings: The prevalence of ID in CHF patients was 55%. Out of 40 patients 55% had relative iron deficiency while 20% had absolute iron deficiency. Both HFrEF and HFpEF patients had ID, but ID was more prevalent among patients with HFpEF.

Conclusion & Significance: ID was present in a significant proportion of adult patients with CHF at UTH, reflecting the increased morbidity encountered by this population. It is certainly plausible that ID may play a role in the pathogenesis and prognosis of HFpEF just like in HFrEF hence screening for ID in CHF patients should be done in order to improve patient quality of life.

Biography:

Sandra Lungu studied Microbiology at the University of Zambia and graduated in 2015. She graduated with a Masters Degree in Human Physiology at the University of Zambia in 2023. She is currently a PhD student at the university of Zambia where her research is based on Biomarkers in Heart failure. Sandra Lungu is passionate about heart failure and improving human health and wellbeing. She is a researcher who is trying to create new pathways for improving healthcare in Zambia. She is an academician who is willing to bridge the research gap in academic institutions and hospitals.

Watsapp